Skip to content

MMED - MiniMed Group, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

MiniMed Group, Inc. Common Stock

MMED · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MMEDMiniMed Group, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $20.88
52-wk low: $10.65
Prev close: $15.15
Mkt cap: $5.68B
P/S: 1.8x
P/B: 1.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$181.6M

MI
Millennium
Israel Englander · Q2 2026 13F
$45.8M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -10.7%
Market cap: $5.7B

Valuation

P/S1.83
P/B1.51

Quality

Operating margin8.4%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MMED
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Market cap: $5.68B

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

-10.7%

Op margin

+8.4%

ROE

-9.1%

$42.8M

position

EP

ExodusPoint

Michael Gelband · Q2 2026 13F

$21.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MMED

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

Reports Sep 1, 2026, in 11 days

EPS expected

$0.09

$0.07 to $0.12

Revenue expected

$828.4M

11 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.02

Change in 30 days

-9.1%

ROA1.7%

Growth